Antidepressant shows promise for sickle cell disease

02/20/2013 | MedicalDaily.com

The antidepressant tranylcypromine was able to stop a mechanism that leads to the development of sickle cell disease in laboratory tests, according to a study in the journal Nature Genetics. The drug allowed the production of fetal hemoglobin in tests of human cells and animals, researchers said.

View Full Article in:

MedicalDaily.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA